Research ArticleClinical Investigation
A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients
Monica Abghari-Gerst, Wesley R. Armstrong, Kathleen Nguyen, Jeremie Calais, Johannes Czernin, David Lin, Namasvi Jariwala, Melissa Rodnick, Thomas A. Hope, Jason Hearn, Jeffrey S. Montgomery, Ajjai Alva, Zachery R. Reichert, Daniel E. Spratt, Timothy D. Johnson, Peter J.H. Scott and Morand Piert
Journal of Nuclear Medicine April 2022, 63 (4) 567-572; DOI: https://doi.org/10.2967/jnumed.121.262412
Monica Abghari-Gerst
1Radiology Department, University of Michigan, Ann Arbor, Michigan;
Wesley R. Armstrong
2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
Kathleen Nguyen
2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
Jeremie Calais
2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
Johannes Czernin
2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
David Lin
3Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Namasvi Jariwala
3Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Melissa Rodnick
1Radiology Department, University of Michigan, Ann Arbor, Michigan;
Thomas A. Hope
3Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Jason Hearn
4Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan;
Jeffrey S. Montgomery
5Urology Department, University of Michigan, Ann Arbor, Michigan;
Ajjai Alva
6Internal Medicine Department, University of Michigan, Ann Arbor, Michigan; and
Zachery R. Reichert
6Internal Medicine Department, University of Michigan, Ann Arbor, Michigan; and
Daniel E. Spratt
4Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan;
Timothy D. Johnson
7Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
Peter J.H. Scott
1Radiology Department, University of Michigan, Ann Arbor, Michigan;
Morand Piert
1Radiology Department, University of Michigan, Ann Arbor, Michigan;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 4
April 1, 2022
A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients
Monica Abghari-Gerst, Wesley R. Armstrong, Kathleen Nguyen, Jeremie Calais, Johannes Czernin, David Lin, Namasvi Jariwala, Melissa Rodnick, Thomas A. Hope, Jason Hearn, Jeffrey S. Montgomery, Ajjai Alva, Zachery R. Reichert, Daniel E. Spratt, Timothy D. Johnson, Peter J.H. Scott, Morand Piert
Journal of Nuclear Medicine Apr 2022, 63 (4) 567-572; DOI: 10.2967/jnumed.121.262412
A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients
Monica Abghari-Gerst, Wesley R. Armstrong, Kathleen Nguyen, Jeremie Calais, Johannes Czernin, David Lin, Namasvi Jariwala, Melissa Rodnick, Thomas A. Hope, Jason Hearn, Jeffrey S. Montgomery, Ajjai Alva, Zachery R. Reichert, Daniel E. Spratt, Timothy D. Johnson, Peter J.H. Scott, Morand Piert
Journal of Nuclear Medicine Apr 2022, 63 (4) 567-572; DOI: 10.2967/jnumed.121.262412